These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18810243)

  • 21. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
    Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
    Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.
    Liu C; Walker JM
    J Neurophysiol; 2006 Dec; 96(6):2984-94. PubMed ID: 16943316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
    Rahn EJ; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L; Howlett AC; Mukhopadhyay S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Cannabinoid Receptor Agonists on Isolated Rat Atria.
    Maggo S; Ashton JC
    J Cardiovasc Pharmacol; 2018 Oct; 72(4):191-194. PubMed ID: 30080756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS.
    González C; Herradón E; Abalo R; Vera G; Pérez-Nievas BG; Leza JC; Martín MI; López-Miranda V
    Diabetes Metab Res Rev; 2011 May; 27(4):331-40. PubMed ID: 21309057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain.
    Guindon J; Desroches J; Dani M; Beaulieu P
    Eur J Pharmacol; 2007 Jul; 568(1-3):173-6. PubMed ID: 17555742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain.
    Costa B; Colleoni M; Conti S; Trovato AE; Bianchi M; Sotgiu ML; Giagnoni G
    Br J Pharmacol; 2004 Jan; 141(1):4-8. PubMed ID: 14662732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
    Cui YY; D'Agostino B; Risse PA; Marrocco G; Naline E; Zhang Y; Chen HZ; Finance O; Rinaldi-Carmona M; Rossi F; Advenier C
    Eur J Pharmacol; 2007 Nov; 573(1-3):206-13. PubMed ID: 17643417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
    Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
    J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid agonists inhibit neuropathic pain induced by brachial plexus avulsion in mice by affecting glial cells and MAP kinases.
    Paszcuk AF; Dutra RC; da Silva KA; Quintão NL; Campos MM; Calixto JB
    PLoS One; 2011; 6(9):e24034. PubMed ID: 21931637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.
    Ulugol A; Karadag HC; Ipci Y; Tamer M; Dokmeci I
    Neurosci Lett; 2004 Nov; 371(2-3):167-70. PubMed ID: 15519750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212-2 mesylate in the hot-plate test in mice: an isobolographic analysis.
    Luszczki JJ; Florek-Łuszczki M
    Pharmacol Rep; 2012; 64(3):723-32. PubMed ID: 22814025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
    Schreiber AK; Neufeld M; Jesus CH; Cunha JM
    Neuropharmacology; 2012 Dec; 63(8):1286-97. PubMed ID: 22959964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cannabinoid agonists on sheep sphincter of oddi in vitro.
    Sarac B; Durmus N; Altun A; Turan M; Kaya T; Sencan M; Bagcivan I
    Pancreatology; 2011; 11(4):428-33. PubMed ID: 21921665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
    Hasanein P; Parviz M; Keshavarz M; Javanmardi K
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):439-49. PubMed ID: 17439413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic thermal hyperalgesia: role of TRPV1 and CB1 receptors of periaqueductal gray.
    Mohammadi-Farani A; Sahebgharani M; Sepehrizadeh Z; Jaberi E; Ghazi-Khansari M
    Brain Res; 2010 Apr; 1328():49-56. PubMed ID: 20211611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
    Radziszewska E; Bojanowska E
    Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.